CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Clinical Benefit of Maintenance Therapy for Advanced Biliary Tract Cancer Patients Showing No Progression after First-Line Gemcitabine Plus Cisplatin

Jaewon Hyung, Bumjun Kim, Changhoon Yoo, Kyo-pyo Kim, Jae Ho Jeong, Heung-Moon Chang, Baek-Yeol Ryoo

Cancer Research and Treatment. 2019;51(3):901-909. Published online 2018 October 4 DOI: https://doi.org/10.4143/crt.2018.326

Clinical Benefit of Maintenance Therapy for Advanced Biliary Tract Cancer Patients Showing No Progression after First-Line Gemcitabine Plus Cisplatin

Jaewon Hyung, Bumjun Kim, Changhoon Yoo, Kyo-pyo Kim, Jae Ho Jeong, Heung-Moon Chang, Baek-Yeol Ryoo

Cancer Research and Treatment. 2019;51(3):901-909

Link1

Link2 Link3

Prognostic factors in patients with advanced biliary tract cancer treated with first-line gemcitabine plus cisplatin chemotherapy: retrospective analysis of 142 patients

H. Engin

Annals of Oncology. 2018;29:v29

Link1 Link2 Link3

Gemcitabine Plus Cisplatin Versus Gemcitabine Chemotherapy for Advanced Biliary Tract Cancer

Jinmyung Park, Jikon Ryu

Annals of Oncology. 2013;24:iv70

Link1 Link2 Link3

Comparison of gemcitabine plus cisplatin versus capecitabine plus cisplatin as first-line chemotherapy for advanced biliary tract cancer

Kwonoh Park, Kyu-pyo Kim, Seongjoon Park, Heung-Moon Chang

Asia-Pacific Journal of Clinical Oncology. 2016;13(1):13-20

Link1 Link2 Link3

Clinical outcomes of gemcitabine, cisplatin plus S-1 in patients with advanced biliary tract cancer

Yusuke Niisato, Hiroyasu Ishida, Tsubasa Onoda, Yudai Shimoyamada, Yuka Ito, Takashi Yamaguchi

Annals of Oncology. 2019;30:vi92

Link1 Link2 Link3

Link4

Gemcitabine Plus Cisplatin Versus Capcitbine Plus Cisplatin for Locally Advanced or Metastatic Biliary Tract Cancer

K. Park, K. Kim

Annals of Oncology. 2014;25:iv245

Link1 Link2 Link3

Second-Line Therapy of S-1 for Patients with Advanced Biliary Tract Cancer After Failure to Cisplatin Plus Gemcitabine

S. Kobayashi, M. Ueno, S. Ohkawa, Y. Gouda, K. Irie, M. Morimoto

Annals of Oncology. 2013;24:ix33

Link1 Link2 Link3

Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

T.J. Eberlein

Yearbook of Surgery. 2011;2011:310-312

Link1 Link2

Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

R.K. Pearson

Yearbook of Gastroenterology. 2010;2010:96-97

Link1 Link2

Gemcitabine plus Cisplatin versus Capecitabine plus Cisplatin as First-Line Chemotherapy for Advanced Biliary Tract Cancer: A Retrospective Cohort Study

Sang Myung Woo, Woo Jin Lee, Ji Hun Kim, Dong Hwan Kim, Sung-Sik Han, Sang-Jae Park, Tae Hyun Kim, Ju Hee Lee, Young Hwan Koh, Eun Kyung Hong

Chemotherapy. 2013;59(3):232-238

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.